SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $121,000 | +72.9% | 935 | 0.0% | 0.01% | +62.5% |
Q3 2019 | $70,000 | -36.9% | 935 | 0.0% | 0.01% | -38.5% |
Q1 2019 | $111,000 | +8.8% | 935 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $102,000 | -32.5% | 935 | 0.0% | 0.01% | -23.5% |
Q3 2018 | $151,000 | +21.8% | 935 | 0.0% | 0.02% | +21.4% |
Q2 2018 | $124,000 | +79.7% | 935 | 0.0% | 0.01% | +75.0% |
Q1 2018 | $69,000 | +68.3% | 935 | +27.2% | 0.01% | +60.0% |
Q4 2017 | $41,000 | +24.2% | 735 | 0.0% | 0.01% | +25.0% |
Q3 2017 | $33,000 | +32.0% | 735 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $25,000 | +13.6% | 735 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $22,000 | +10.0% | 735 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $20,000 | -55.6% | 735 | 0.0% | 0.00% | -62.5% |
Q3 2016 | $45,000 | +221.4% | 735 | 0.0% | 0.01% | +166.7% |
Q2 2016 | $14,000 | 0.0% | 735 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $14,000 | -50.0% | 735 | 0.0% | 0.00% | -40.0% |
Q4 2015 | $28,000 | +16.7% | 735 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $24,000 | +9.1% | 735 | 0.0% | 0.01% | +25.0% |
Q2 2015 | $22,000 | +120.0% | 735 | 0.0% | 0.00% | +100.0% |
Q1 2015 | $10,000 | -9.1% | 735 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $11,000 | -31.2% | 735 | 0.0% | 0.00% | -33.3% |
Q3 2014 | $16,000 | -27.3% | 735 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $22,000 | +22.2% | 735 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $18,000 | – | 735 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |